Lelia Delamarre

Company: Genentech

Job title: Director - Cancer Immunology Research & Distinguished Scientist

Seminars:

Enhancing Vaccine Efficacy Through Improved T Cell Priming to Advance Neoantigen Discovery & Antigen Presentation 8:30 am

• Investigating dendritic cell biology and antigen presentation pathways that drive effective CD8+ and CD4+ T cell priming to increase functional T cell infiltration and improve vaccine-induced tumor clearance • Applying refined antigen selection strategies to expand immunogenicity across tumor types to enhance breadth of response and overcome immune evasion mechanismsRead more

day: Conference Day One